Hypermutability and compensatory adaptation in antibiotic-resistant bacteria

The American Naturalist
G G PerronAngus Buckling

Abstract

Hypermutable (mutator) bacteria have been associated with the emergence of antibiotic resistance. A simple yet untested prediction is that mutator bacteria are able to compensate more quickly for pleiotropic fitness costs often associated with resistance, resulting in the maintenance of resistance in the absence of antibiotic selection. By using experimental populations of a wild-type and a mutator genotype of the pathogenic bacterium Pseudomonas aeruginosa, we show that mutator bacteria can evolve resistance to antibiotics more rapidly than wild-type bacteria and, crucially, that mutators are better able to compensate for the fitness cost of resistance, to the extent that all costs of resistance were entirely compensated for in mutators. When competed against immigrant antibiotic-susceptible bacteria in the absence of antibiotics, antibiotic resistance remained at a high level in mutator populations but disappeared in wild-type populations. These results suggest that selection for mutations that offset the fitness cost associated with antibiotic resistance may help to explain the high frequency of mutator bacteria and antibiotic resistance observed in chronic infections.

Citations

Mar 19, 2011·The Journal of Antimicrobial Chemotherapy·Kamilia AbdelraoufVincent H Tam
Dec 12, 2012·Biology Letters·Ram P MaharjanThomas Ferenci
Jun 26, 2012·Applied and Environmental Microbiology·Gabriel G PerronAngus Buckling
Jun 7, 2011·Annual Review of Phytopathology·Linda L KinkelDaniel C Schlatter
Aug 27, 2011·Journal of Genetics·R Jayaraman
Aug 16, 2011·Current Opinion in Pharmacology·Rafael Cantón, Patricia Ruiz-Garbajosa
Nov 27, 2015·Molecular Biology and Evolution·Sébastien WielgossAlex R Hall
Jul 28, 2011·Evolution; International Journal of Organic Evolution·Alex R Hall, R Craig MacLean
Oct 3, 2012·Evolutionary Applications·Patricia Escobar-PáramoMichael E Hochberg
Oct 3, 2012·Evolutionary Applications·Quan-Guo Zhang, Angus Buckling
Apr 11, 2015·Evolutionary Applications·Alex R HallMartin Ackermann
Apr 11, 2015·Evolutionary Applications·Fernando BaqueroTeresa M Coque
Apr 11, 2015·Evolutionary Applications·Gabriel G PerronSarah Cobey
Oct 20, 2012·FEMS Microbiology Reviews·Carolina Díaz Arenas, Tim F Cooper
Feb 27, 2015·Proceedings. Biological Sciences·Alejandro CouceJesús Blázquez
Nov 5, 2014·The Journal of Antimicrobial Chemotherapy·Hava LoftonDan I Andersson
Oct 30, 2018·Drug Development Research·Teresa NogueiraJoël Pothier
Mar 25, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ville HoikkalaLotta-Riina Sundberg
Apr 5, 2018·Frontiers in Microbiology·Claudia Ibacache-QuirogaJesus Blázquez
Apr 5, 2017·The Journal of Infectious Diseases·Edward Geisinger, Ralph R Isberg
Oct 23, 2018·Evolutionary Applications·Claire E Moulton-Brown, Ville-Petri Friman
Dec 3, 2020·International Journal of Antimicrobial Agents·Olga A ChernovaRustam I Aminov
Jun 3, 2021·Cells·Esmeralda Cebrián-SastreAlfredo Castañeda-García

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M García-CastilloRafael Cantón
Proceedings of the National Academy of Sciences of the United States of America
Valerie W C SooWayne M Patrick
© 2021 Meta ULC. All rights reserved